Cellares Patents – Insights & Stats (Updated 2025)

Cellares has a total of 54 patents globally, out of which 17 have been granted. Of these 54 patents, more than 94% patents are active. United States of America is where Cellares has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, USA seems to be the main focused R&D centre and also is the origin country of Cellares.

Cellares founded in 2019, is the first Integrated Development and Manufacturing Organization (IDMO) dedicated to scaling cell therapy manufacturing. Its flagship technology, the Cell Shuttle, offers fully automated, end-to-end production on a high-throughput platform, deployed through global Smart Factories. By partnering with Cellares, academic institutions, biotech’s, and Pharma companies can accelerate development, reduce costs and failures, and expand global patient access to life-saving therapies.

Do read about some of the most popular patents of Cellares which have been covered by us in this article and also you can find Cellares patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Cellares patent portfolio.

How many patents does Cellares have?

Cellares has a total of 54 patents globally. These patents belong to 18 unique patent families. Out of 54 patents, 51 patents are active.

How Many Patents did Cellares File Every Year?

Cellares Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCellares Applications FiledCellares Patents Granted
202526
2024327
202383
202231
20219

How many Cellares patents are Alive/Dead?

Worldwide Patents

Cellares Patent Portfolio

How Many Patents did Cellares File in Different Countries?

Cellares Worldwide Patent Filing Trend

Countries in which Cellares Filed Patents

CountryPatents
United States of America29
Europe (EPO)5
China2
India2
Japan1
Hong Kong (S.A.R.)1
Korea (South)1
Canada1

Where are Research Centres of Cellares Patents Located?

The Research Centre for all the Cellares patents is the United States of America.

10 Best Cellares Patents

US11376587B2 is the most popular patent in the Cellares portfolio. It has received 14 citations so far from companies like Stamm Vegh Corporation, Cellino Biotech and Biolinq.

Below is the list of 10 most cited patents of Cellares:

Publication NumberCitation Count
US11376587B214
US12157119B213
US20240255537A111
US11701654B211
US20240326043A19
WO2024112702A18
US11826756B28
US11872557B27
US20240254426A17
US20240165613A17

What Percentage of Cellares US Patent Applications were Granted?

Cellares (Excluding its subsidiaries) has filed 17 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 5 have been granted leading to a grant rate of 100.0%.

Below are the key stats of Cellares patent prosecution at the USPTO.

EA Stats

Which Law Firms are managing US Patents for Cellares?

Law FirmTotal ApplicationsSuccess Rate
Cooley Llp17100.00%

What are Cellares key innovation segments?

What Technologies are Covered by Cellares?

The chart below distributes patents filed by Cellares in different countries on the basis of the technology protected in patents. It also represents the markets where Cellares thinks it’s important to protect particular technological inventions.

R&D Focus: How has Cellares search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Cellares?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.